ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy aims to fight tough blood cancers
Disease control Recruiting nowThis study tests a new treatment called CTD402 for people aged 12 and older with T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (T-LBL) that has come back or not responded to other treatments. Participants receive one infusion of CTD402 and are monitored fo…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: BIOHENG THERAPEUTICS US LLC • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New hope for kids with relapsed leukemia: targeted drug trial launches
Disease control Recruiting nowThis study tests a drug called tafasitamab in children aged 3 to 17 with a type of leukemia (B-cell ALL) that has come back or not responded to treatment. The goal is to see if the drug is safe and can delay or prevent the cancer from returning after a stem cell transplant. About…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated May 26, 2026 12:05 UTC